ES8704155A1 - Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas - Google Patents

Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas

Info

Publication number
ES8704155A1
ES8704155A1 ES551500A ES551500A ES8704155A1 ES 8704155 A1 ES8704155 A1 ES 8704155A1 ES 551500 A ES551500 A ES 551500A ES 551500 A ES551500 A ES 551500A ES 8704155 A1 ES8704155 A1 ES 8704155A1
Authority
ES
Spain
Prior art keywords
alkyl
inclusive
integer
atom
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551500A
Other languages
English (en)
Other versions
ES551500A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES551500A0 publication Critical patent/ES551500A0/es
Publication of ES8704155A1 publication Critical patent/ES8704155A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE NUEVAS 4(3H)-PIRIMIDONAS 2,5-DISUSTITUIDAS. CONSISTE EN HACER REACCIONAR, EN UN DISOLVENTE INERTE Y A UNA TEMPERATURA COMPRENDIDA ENTRE LA TEMPERATURA AMBIENTE Y LA DE REFLUJO DEL DISOLVENTE, UN COMPUESTO DE FORMULA (II) CON HSCH2CH2NH2, PARA PRIDUCIR NUEVAS 4(3H)-PIRIMIDONAS 2,5-DISUSTITUIDAS DE FORMULA (I) DONDE M ES UN ENTERO COMPRENDIDO ENTRE 0 Y 2 Y A ES FENILO, FURILO, TIENILO, PIRIDILO, TIAZOLILO, IMIDAZOLILO, OXAZOLILO, OXADIAZOLILO, TIADIAZOLILO, TRIAZOLILO, ISOXAZOLILO, ISOTIAZOLILO, PIRIMIDINILO, PIRAZOLILO, PIRIDAZINILO O PIRAZINILO. TIENE APLICACIONES FARMACOLOGICAS POR SER H2-ANTAGONISTA RECEPTOR DE LA HISTAMINA, EFECTIVA EN LOS ESTADOS PATOLOGICOS DE HIPERSECRECION.-
ES551500A 1983-09-21 1986-01-31 Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas Expired ES8704155A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/534,426 US4772704A (en) 1983-09-21 1983-09-21 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity

Publications (2)

Publication Number Publication Date
ES551500A0 ES551500A0 (es) 1987-03-16
ES8704155A1 true ES8704155A1 (es) 1987-03-16

Family

ID=24129972

Family Applications (4)

Application Number Title Priority Date Filing Date
ES536054A Expired ES8607253A1 (es) 1983-09-21 1984-09-19 Un procedimiento para la preparacion de nuevos 4 (3h)-pirimidonas 2,5-disustituidas.
ES544213A Expired ES8704465A1 (es) 1983-09-21 1985-06-14 Un procedimiento para la preparacion de nuevas 4 (3h)-piri- midonas 2,5-disustituidas
ES551501A Expired ES8702897A1 (es) 1983-09-21 1986-01-31 Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas
ES551500A Expired ES8704155A1 (es) 1983-09-21 1986-01-31 Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES536054A Expired ES8607253A1 (es) 1983-09-21 1984-09-19 Un procedimiento para la preparacion de nuevos 4 (3h)-pirimidonas 2,5-disustituidas.
ES544213A Expired ES8704465A1 (es) 1983-09-21 1985-06-14 Un procedimiento para la preparacion de nuevas 4 (3h)-piri- midonas 2,5-disustituidas
ES551501A Expired ES8702897A1 (es) 1983-09-21 1986-01-31 Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas

Country Status (36)

Country Link
US (1) US4772704A (es)
JP (1) JPH0643310B2 (es)
KR (1) KR900001198B1 (es)
AR (2) AR242385A1 (es)
AT (1) AT387965B (es)
AU (1) AU583479B2 (es)
BE (1) BE900652A (es)
CA (1) CA1260463A (es)
CH (1) CH665840A5 (es)
CS (1) CS249147B2 (es)
CY (1) CY1561A (es)
DD (1) DD226881A5 (es)
DE (1) DE3434578A1 (es)
DK (1) DK162987C (es)
ES (4) ES8607253A1 (es)
FI (1) FI83868C (es)
FR (1) FR2552082B1 (es)
GB (1) GB2146994B (es)
GR (1) GR80439B (es)
HK (1) HK73790A (es)
HU (1) HU193227B (es)
IE (1) IE58083B1 (es)
IL (1) IL72990A (es)
IT (1) IT1176739B (es)
LU (1) LU85550A1 (es)
NL (1) NL8402898A (es)
NO (1) NO161561C (es)
NZ (1) NZ209572A (es)
OA (1) OA07820A (es)
PT (1) PT79256B (es)
SE (1) SE463209B (es)
SG (1) SG60890G (es)
YU (1) YU45205B (es)
ZA (1) ZA847345B (es)
ZM (1) ZM4984A1 (es)
ZW (1) ZW16084A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2873340B2 (ja) * 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質tan―1057,その製造法および用途
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (es) * 1978-02-13 1983-03-05 Smith Kline French Lab
ES477520A1 (es) * 1978-02-25 1979-06-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevas penicilinas.
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
AU531142B2 (en) * 1979-04-04 1983-08-11 Smith Kline & French Laboratories Limited 2 amino- pyimindones
CA1140129A (en) * 1979-08-21 1983-01-25 Ronald J. King 4-pyrimidone derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
US4468399A (en) * 1981-12-28 1984-08-28 Eli Lilly And Company 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives

Also Published As

Publication number Publication date
CA1260463A (en) 1989-09-26
JPS6087271A (ja) 1985-05-16
NO843726L (no) 1985-03-22
AR242789A1 (es) 1993-05-31
US4772704A (en) 1988-09-20
KR850002259A (ko) 1985-05-10
IE58083B1 (en) 1993-06-30
DD226881A5 (de) 1985-09-04
SE8404729D0 (sv) 1984-09-20
GR80439B (en) 1985-01-22
PT79256A (en) 1984-10-01
ZA847345B (en) 1985-06-26
HU193227B (en) 1987-08-28
NL8402898A (nl) 1985-04-16
CH665840A5 (de) 1988-06-15
AU3335184A (en) 1985-03-28
ES551500A0 (es) 1987-03-16
FI843643A0 (fi) 1984-09-18
FI843643L (fi) 1985-03-22
NO161561B (no) 1989-05-22
NZ209572A (en) 1988-05-30
AT387965B (de) 1989-04-10
GB8423863D0 (en) 1984-10-24
DK450484A (da) 1985-03-22
ES8607253A1 (es) 1986-05-16
HK73790A (en) 1990-09-28
IE842406L (en) 1985-03-21
AU583479B2 (en) 1989-05-04
PT79256B (en) 1986-11-20
YU161384A (en) 1987-12-31
ES536054A0 (es) 1986-05-16
ES8702897A1 (es) 1987-01-16
IT8422744A0 (it) 1984-09-20
FI83868C (fi) 1991-09-10
DK450484D0 (da) 1984-09-20
ES551501A0 (es) 1987-01-16
DE3434578A1 (de) 1985-04-11
ZW16084A1 (en) 1985-01-16
DK162987C (da) 1992-06-01
CY1561A (en) 1991-03-22
IL72990A (en) 1990-07-12
CS249147B2 (en) 1987-03-12
DK162987B (da) 1992-01-06
AR242385A1 (es) 1993-03-31
OA07820A (fr) 1986-11-20
GB2146994A (en) 1985-05-01
ZM4984A1 (en) 1985-05-21
SE463209B (sv) 1990-10-22
KR900001198B1 (ko) 1990-02-28
LU85550A1 (fr) 1985-06-04
SG60890G (en) 1990-09-07
SE8404729L (sv) 1985-03-22
YU45205B (en) 1992-05-28
BE900652A (fr) 1985-03-21
ATA300984A (de) 1988-09-15
GB2146994B (en) 1987-09-03
HUT35259A (en) 1985-06-28
JPH0643310B2 (ja) 1994-06-08
FR2552082B1 (fr) 1987-02-20
IT8422744A1 (it) 1986-03-20
FI83868B (fi) 1991-05-31
ES8704465A1 (es) 1987-04-01
IT1176739B (it) 1987-08-18
ES544213A0 (es) 1987-04-01
NO161561C (no) 1989-08-30
FR2552082A1 (fr) 1985-03-22

Similar Documents

Publication Publication Date Title
GB2067987B (en) 3,4-disubstituted-1,2,5-thiadiazole-1-oxides and 1,1 dioxides
IE782238L (en) Analgesics
NZ284654A (en) Oxazolyl substituted 3,5-dioxo-oxadiazolidine or 2,4-dioxo-thiazolidine derivatives and medicaments
ES458689A1 (es) Procedimiento de preparacion de nuevos derivados del ditiol-1,2.
ES469900A1 (es) Un procedimiento para la preparacion de derivados de m-feno-xibenzamida
ES8704155A1 (es) Un procedimiento para la preparacion de nuevas 4(3h)-piri-midonas 2,5 disustituidas
IE41244L (en) Pyridobenzodiazepinones
ES446496A1 (es) Procedimiento para la preparacion de nuevas 9-alcohila mi- noeritromicinas.
ES417006A1 (es) Procedimiento para la preparacion de 4-fenil-imidazolinas.
ES470783A1 (es) Procedimiento de preparacion de aminoalcoxibenzofuranos
DE3579827D1 (de) 3,4-disubstituierte-1,2,5-oxadiazole mit histamin h2-rezeptor-antagonisten-aktivitaet.
EP0125315A4 (en) PHENOXYAMINOPROPANOL DERIVATIVES.
NZ296285A (en) Inhibiting physiological conditions associated with bradykinin using a benzothiophene such as raloxifene
ES468586A1 (es) Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas.
ES448696A1 (es) Procedimiento para la preparacion de 4-fenil-imidazolinas sustituidas.
GB1320548A (en) Nitrofurylaminoalkoxy-pyrimidines
DK10684A (da) Farmaceutisk praeparat til behandling af peptisk ulcus
PH15866A (en) Substituted 4-amino 2,6-diaryl-tetrahydrothiopyrans and salts thereof,and use as antidepressants

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001